DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis (DISON I)
DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis- A Multicenter Prospective Pilot Study
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Matt Sprinkel
- Telefonnummer: +1 650 465 6200
- E-mail: matt@ventarissurgical.com
Studiesteder
-
-
-
Buenos Aires, Argentina
- Hospital Aleman
-
Kontakt:
- Head of Clinical Investigations
- Telefonnummer: 2286/ 7039 (011) 4827 7000
- E-mail: pperez@hospitalaleman.com
-
-
-
-
-
Montreal, Canada
- Centre hospitalier de l'Université de Montréal (CHUM)
-
Kontakt:
- Research Coordinator
- Telefonnummer: 22931 514-890-8000
- E-mail: abbas.guennoun.chum@ssss.gouv.qc.ca
-
-
-
-
-
Hong Kong, Hong Kong
- The Chinese University of Hong Kong
-
Kontakt:
- Research Coordinator
- Telefonnummer: 3505 2211
- E-mail: francolai@surgery.cuhk.edu.hk
-
-
-
-
-
Nadiād, Indien
- Muljibhai Patel Urological Hospital
-
Kontakt:
- Research Coordinator
- Telefonnummer: 912682520328
- E-mail: monil.parmar@mpuh.in
-
-
-
-
-
Tauranga, New Zealand
- Tauranga Urology Research Limited
-
Kontakt:
- Research Coordinator
- Telefonnummer: (07) 579 0466
- E-mail: marg@urobop.co.nz
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Diagnosis of calyceal and/or renal pelvis calculi
- Age from 18 through 85 years
- Maximum stone diameter between 0.5cm - 2.0cm as assessed by Non-Contrast CT scan (≤ 2 mm slice thickness) within 90 days prior to treatment
- Willing and able to comply with all study requirements
- Signs study-specific informed consent form
Exclusion Criteria:
- Diagnosis of calculus of the ureter
- BMI ≥ 42
- Significant renal impairment: stage 3a CKD or higher (eGFR <59mL/min)
- Active infection, including urinary tract infection
- Urological anatomic/congenital abnormalities
- Previous history of struvite stone in the same renal unit
- Taking anticoagulants that cannot be stopped before and after procedure or known coagulopathy or platelet disorder (except aspirin below 100mg/d)
- History of gross hematuria
- Solitary functioning kidney
- Known allergy to device materials
- Any severe illness that would prevent complete study participation or confound study results
- Serious concurrent medical conditions such as heart disease (e.g., myocardial infarction within 30 days, congestive heart failure - NYHA Class IV), pulmonary disease or uncontrolled diabetes.
- History of open-heart surgery, or cardiac arrest < 180 days prior to the date of informed consent
- ASA III or higher
- Taking systemic immune suppressants
- Dementia or psychiatric condition that prevents the participant from completing required follow up
- Contraindication to both general and spinal anesthesia
- Participating in another investigational study that could affect responses to the study device
- Unwilling to accept a transfusion should one be required
- Pregnant or considering getting pregnant within the next 3 months
- Undergoing bilateral ureteroscopy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Investigational endourological device used during retrograde intrarenal surgery.
|
Investigational endourological device used during retrograde intrarenal surgery.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Procedure success
Tidsramme: Intraoperative
|
Successful completion of the planned procedure without device-related technical complications.
|
Intraoperative
|
|
Stone-Free Status
Tidsramme: 30 days post-procedure
|
Absence of residual stone fragments on CT imaging
|
30 days post-procedure
|
|
Serious Adverse Device Effects (SADEs)
Tidsramme: 30 days post-procedure
|
Serious adverse device effects related to the investigational device.
|
30 days post-procedure
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Stone-Free Categories
Tidsramme: 30 days post-procedure
|
Stone-free status according to predefined categories.
|
30 days post-procedure
|
|
Intrarenal pressure assessment
Tidsramme: Intraoperative
|
Intrarenal pressure measured during the procedure.
|
Intraoperative
|
|
Procedure duration
Tidsramme: Intraoperative
|
Duration of the surgical procedure.
|
Intraoperative
|
|
Stone clearance
Tidsramme: Intraoperative
|
Amount of stone material removed during the procedure.
|
Intraoperative
|
|
Residual stone burden
Tidsramme: 30 days post-procedure
|
Residual stone burden assessed by imaging.
|
30 days post-procedure
|
|
Device- or procedure-related adverse event
Tidsramme: From procedure to 12 months post-procedure
|
Device- or procedure-related adverse event.
|
From procedure to 12 months post-procedure
|
|
Stone-related healthcare utilization
Tidsramme: From procedure to 12 months post-procedure
|
Healthcare utilization related to recurrent stone symptoms in the treated kidney.
|
From procedure to 12 months post-procedure
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Mandlige urogenitale sygdomme
- Calculi
- Patologiske Tilstande, Anatomiske
- Nyresygdomme
- Urologiske sygdomme
- Urogenitale sygdomme hos kvinder
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Urinvejsregning
- Patologiske tilstande, tegn og symptomer
- Nyre Calculi
- Nephrolithiasis
- Urolithiasis
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- VS-0001
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .